Frederick CPA - Minerva Neurosciences CFO VP
| NERV Stock | USD 2.26 0.02 0.89% |
CFO
Frederick CPA is CFO VP of Minerva Neurosciences
| Age | 58 |
| Address | 1500 District Avenue, Burlington, MA, United States, 01803 |
| Phone | 617 600 7373 |
| Web | https://www.minervaneurosciences.com |
Minerva Neurosciences Management Efficiency
The company has return on total asset (ROA) of (0.2891) % which means that it has lost $0.2891 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.7509) %, meaning that it created substantial loss on money invested by shareholders. Minerva Neurosciences' management efficiency ratios could be used to measure how well Minerva Neurosciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to climb to 1.11 in 2024, whereas Return On Tangible Assets are likely to drop (0.75) in 2024. At this time, Minerva Neurosciences' Total Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 52.9 M in 2024, whereas Other Assets are likely to drop slightly above 1.3 M in 2024.Similar Executives
| Found 6 records | CFO Age | ||
| George CPA | Eyepoint Pharmaceuticals | 59 | |
| Douglas JD | Leap Therapeutics | 55 | |
| Patrick CPA | In8bio Inc | 40 | |
| Franco CPA | Biomea Fusion | 43 | |
| Matt Zuga | Acumen Pharmaceuticals | N/A | |
| Adam Mostafa | X4 Pharmaceuticals | 44 | |
Management Performance
| Return On Equity | -6.75 | ||||
| Return On Asset | -0.29 |
Minerva Neurosciences Leadership Team
Elected by the shareholders, the Minerva Neurosciences' board of directors comprises two types of representatives: Minerva Neurosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Minerva. The board's role is to monitor Minerva Neurosciences' management team and ensure that shareholders' interests are well served. Minerva Neurosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Minerva Neurosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, CFO VP | ||
| Ramana Kuchibhatla, Senior Development | ||
| MBA FCMA, President | ||
| Remy Luthringer, Executive Vice President and Head of Research & Development (R&D) | ||
| FCMA FCMA, President | ||
| William Boni, Vice Communications | ||
| Joseph Reilly, COO and Sr. VP | ||
| Frederick CPA, CFO VP | ||
| Pr MD, Chief Officer |
Minerva Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Minerva Neurosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -6.75 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | (10.86 M) | ||||
| Shares Outstanding | 6.99 M | ||||
| Shares Owned By Insiders | 22.26 % | ||||
| Shares Owned By Institutions | 30.47 % | ||||
| Number Of Shares Shorted | 7.08 K | ||||
| Price To Earning | 69.58 X | ||||
| Price To Book | 2.68 X | ||||
| Price To Sales | 1.87 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Minerva Stock Analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.